Company Search:
Advanced Search
Sponsored Links
Uluru Incorporation Company Snapshot
Uluru Incorporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Uluru Incorporation with three other companies in this sector in the United States: Fortress Biotech Inc (2015 sales of $863,000.00 of which 100% was Biopharmaceuticals), Genvec Inc ($885,000.00 of which 100% was Research & Development), and Steadymed Ltd ($869,000.00 of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2015, sales at Uluru Incorporation were $935,739.00 . This is an increase of 8.3% versus 2014, when the company's sales were $863,857.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Uluru Incorporation
  Stock Performance Chart for Uluru Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): .07
(Figures in U.S. Dollars)
1 Week -7.0%   13 Weeks -15.4%  
4 Weeks 46.7%   52 Weeks -40.0%  
Uluru Incorporation Key Data:
  Ticker: ULUR Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 935,739
(Year Ending Jan 2016).
Employees: 7
  Currency: U.S. Dollars Market Cap: 4,156,312
  Fiscal Yr Ends: December Shares Outstanding: 62,974,431
  Share Type: Common Closely Held Shares: 35,204,664
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.